| Contents |
- Vial: FOXO4-DRI 10mg/vial × 2
- Ampoule: 2ml Bacteriostatic Water
|
| Description |
FOXO 4DR™ is an advanced senolytic peptide formulation containing FOXO4-DRI, designed to support healthy ageing by targeting cellular senescence. It is widely studied for its potential role in selectively clearing senescent (aged or dysfunctional) cells, which naturally accumulate over time and may contribute to age-related decline in tissue function and recovery.
By helping reduce the burden of senescent cells, FOXO 4DR™ supports cellular renewal, tissue regeneration, and overall physiological resilience. It may contribute to improved muscle recovery, metabolic health, cognitive wellness, healthy inflammatory balance, and enhanced cellular energy.
FOXO 4DR™ is commonly incorporated into longevity and regenerative wellness protocols to support healthy ageing, cellular rejuvenation, improved vitality, and long-term tissue health. |
| Administration |
Administer via Subcutaneous (SC) injection under the supervision of a qualified healthcare professional. |
| Storage |
- Before reconstitution: Store at room temperature, away from heat, moisture, and direct sunlight.
- After reconstitution: Refrigerate between 2–8°C.
|
| Dosage |
Typical dosage: 250–500 mcg per day. Dosage may be adjusted according to individual requirements, treatment goals, and professional guidance. Use under medical supervision. |
| Indication |
FOXO 4DR™ may be used in protocols supporting:
- Healthy ageing and longevity
- Cellular rejuvenation and senescent cell clearance
- Tissue regeneration and repair
- Muscle recovery and physical resilience
- Metabolic health and cellular energy
- Healthy inflammatory response
- Cognitive wellness and overall vitality
|
| Contraindications |
Do not use FOXO 4DR™ if:
- Hypersensitive to FOXO4-DRI or any formulation components
- Avoid use during pregnancy or lactation
- Individuals with severe uncontrolled medical conditions without medical supervision
|
| Special Precautions |
- Use only under medical supervision.
- Individuals with chronic illnesses, autoimmune disorders, active malignancies, or those receiving immunomodulatory or anticancer therapies should consult a healthcare professional before use.
- Long-term clinical safety data remains limited.
|
| Adverse Drug Reactions |
- Generally well tolerated
- Common: Injection-site irritation, redness, or discomfort
- Others: Temporary fatigue or headache, mild nausea or dizziness
- Rare: Allergic or hypersensitivity reactions
|
| Drug Interactions |
Limited interaction data are available. Use cautiously with:
- Immunomodulatory medications
- Anti-inflammatory therapies
- Anticancer or regenerative treatments
- Other senolytic or longevity-focused therapies
Consult a healthcare professional before combining with other treatments. |
| Disclaimer |
Images shown on the website are for representation purposes only and may differ from the actual product. Packaging designs may change without prior notice. Use only under professional medical supervision. |
